These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 4061453)
21. Aluminum-related osteomalacia in renal-failure patients. Vick KE; Johnson CA Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471 [TBL] [Abstract][Full Text] [Related]
22. Aluminium overload of parathyroid glands in haemodialysed patients with hyperparathyroidism: effect on bone remodelling. Berland Y; Charbit M; Henry JF; Toga M; Cano JP; Olmer M Nephrol Dial Transplant; 1988; 3(4):417-22. PubMed ID: 3140127 [TBL] [Abstract][Full Text] [Related]
23. Elevated bone aluminum content in dialysis patients without osteomalacia. McCarthy JT; Kurtz SB; McCall JT Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380 [TBL] [Abstract][Full Text] [Related]
24. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization. Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831 [No Abstract] [Full Text] [Related]
25. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115 [TBL] [Abstract][Full Text] [Related]
26. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism. Pizzarelli F; Ballanti P; Costantini S; Mocetti P; Giordano R; Della Rocca C; Fabrizi F; Bonucci E; Maggiore Q Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068 [TBL] [Abstract][Full Text] [Related]
27. Management of bone disease in the dialysis patient. Crooks PW; Coburn JW Blood Purif; 1985; 3(1-3):27-41. PubMed ID: 3913448 [TBL] [Abstract][Full Text] [Related]
28. The role of parathyroid function and parathyroidectomy in the outcome of aluminium-related dialysis encephalopathy. Campistrus de Gencarelli N; Cournot-Witmer G; Zingraff J; Drüeke T Nephrol Dial Transplant; 1986; 1(3):192-8. PubMed ID: 3110673 [TBL] [Abstract][Full Text] [Related]
29. The effect of high parathyroid hormone levels on the development of aluminum-induced osteomalacia in the rat. Felsenfeld AJ; Machado L; Rodriguez M J Am Soc Nephrol; 1991 Jan; 1(7):970-9. PubMed ID: 1883967 [TBL] [Abstract][Full Text] [Related]
30. [Bone and aluminum]. Wendling D; Guidet M Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):705-13. PubMed ID: 3103201 [No Abstract] [Full Text] [Related]
31. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs. Quarles LD; Dennis VW; Gitelman HJ; Harrelson JM; Drezner MK J Clin Invest; 1985 May; 75(5):1441-7. PubMed ID: 3998143 [TBL] [Abstract][Full Text] [Related]
32. The interaction of parathyroid hormone and aluminum in renal osteodystrophy. Slatopolsky E Kidney Int; 1987 Mar; 31(3):842-54. PubMed ID: 3573543 [No Abstract] [Full Text] [Related]
33. Suppression of parathyroid hormone secretion by aluminum. Morrissey J; Rothstein M; Mayor G; Slatopolsky E Kidney Int; 1983 May; 23(5):699-704. PubMed ID: 6308327 [TBL] [Abstract][Full Text] [Related]